Renal angiotensin II receptor regulation and renin-angiotensin system inhibition in one-kidney, one clip hypertensive rats

被引:9
作者
Amiri, F
Haddad, G
Garcia, R
机构
[1] Univ Montreal, Clin Res Inst Montreal, Lab Expt Hypertens & Vascoact Peptides, Montreal, PQ H3C 3J7, Canada
[2] Amer Univ Beirut, Dept Pharmacol, Beirut, Lebanon
关键词
angiotensin II receptors; one-kidney; one clip rat; renovascular hypertension; angiotensin converting enzyme inhibition; angiotensin II receptor antagonism; captopril; TCV-116; Sprague-Dawley rat;
D O I
10.1097/00004872-199917020-00013
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective To characterize glomerular and preglomerular vascular angiotensin II receptors during the acute phase of nonrenin-dependent one-kidney, one clip hypertension in rats, using the angiotensin II antagonists losartan and PD 123319, and to investigate their regulation after renin-angiotensin system blockade with either an angiotensin converting enzyme inhibitor, captopril, or an angiotensin II receptor antagonist, TCV-116. Materials and methods One-kidney, one clip hypertension was produced in male Sprague-Dawley rats by placing a silver clip (internal diameter 0.2 mm) on the left renal artery and removing the contralateral kidney, After 1, 2 or 4 weeks, the rats were killed, and their glomerular and preglomerular vascular membranes were purified. Competitive binding studies were performed using specific angiotensin II antagonists. Similarly, one-kidney, one clip hypertension was allowed to develop for 2 weeks before treatment with captopril or TCV-116 for 2 weeks. Results Competitive binding studies showed that only the angiotensin II type 1 (AT(1)) receptor was detected on both glomeruli and preglomerular vessels of all groups. The vascular AT(1) receptor density was significantly higher in the 1 and 2 week one-kidney, one clip groups, but the glomerular receptor density was not different in these rats compared with age-matched uninephrectomized controls. The glomerular receptor density was significantly higher in captopril-treated rats and significantly lower in TCV-116-treated rats compared with untreated and control rats, but no significant changes were detected in any groups in vascular AT(1) receptor density. Conclusions Angiotensin II receptors on preglomerular vessels and glomeruli are differentially regulated during the early phase of hypertension and after renin-angiotensin system blockade. Vascular angiotensin II receptors are upregulated in the early phase of hypertension whereas glomerular angiotensin II receptors are not. However, after renin-angiotensin system blockade, glomerular but not vascular angiotensin II receptors were differentially regulated according to the type of blockade. (C) Lippincott Williams & Wilkins.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 38 条
[1]   Differential regulation of renal glomerular and preglomerular vascular angiotensin II receptors [J].
Amiri, F ;
Garcia, R .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (05) :E810-E815
[2]   Renal angiotensin II receptor regulation in two-kidney, one clip hypertensive rats - Effect of ACE inhibition [J].
Amiri, F ;
Garcia, R .
HYPERTENSION, 1997, 30 (03) :337-344
[3]   ANTIHYPERTENSIVE EFFECT OF PROLONGED BLOCKADE OF ANGIOTENSIN FORMATION IN BENIGN AND MALIGNANT, ONE-KIDNEY AND 2-KIDNEY GOLDBLATT HYPERTENSIVE RATS [J].
BENGIS, RG ;
COLEMAN, TG .
CLINICAL SCIENCE, 1979, 57 (01) :53-62
[4]   EFFECT IN CONSCIOUS DOG OF CONSTRICTION OF RENAL ARTERY TO A SOLE REMAINING KIDNEY ON HAEMODYNAMICS, SODIUM BALANCE, BODY FLUID VOLUMES, PLASMA RENIN CONCENTRATION AND PRESSOR RESPONSIVENESS TO ANGIOTENSIN [J].
BIANCHI, G ;
TENCONI, LT ;
LUCCA, R .
CLINICAL SCIENCE, 1970, 38 (06) :741-+
[5]   ANGIOTENSIN-II RECEPTOR SUBTYPES - CHARACTERIZATION, SIGNALING MECHANISMS, AND POSSIBLE PHYSIOLOGICAL IMPLICATIONS [J].
BOTTARI, SP ;
DEGASPARO, M ;
STECKELINGS, UM ;
LEVENS, NR .
FRONTIERS IN NEUROENDOCRINOLOGY, 1993, 14 (02) :123-171
[6]   THE LIGAND-BINDING SIGNATURES OF THE RAT AT(1A), AT(1B) AND THE HUMAN AT(1) RECEPTORS ARE ESSENTIALLY IDENTICAL [J].
CHIU, AT ;
DUNSCOMB, J ;
KOSIEROWSKI, J ;
BURTON, CRA ;
SANTOMENNA, LD ;
CORJAY, MH ;
BENFIELD, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) :440-449
[7]   IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES [J].
CHIU, AT ;
HERBLIN, WF ;
MCCALL, DE ;
ARDECKY, RJ ;
CARINI, DJ ;
DUNCIA, JV ;
PEASE, LJ ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :196-203
[8]   PHARMACOLOGY OF ANGIOTENSIN-II RECEPTORS IN THE KIDNEY [J].
DEGASPARO, M ;
LEVENS, NR .
KIDNEY INTERNATIONAL, 1994, 46 (06) :1486-1491
[9]  
DELEON H, 1992, RECEPTOR, V2, P253
[10]   EFFECTS OF CONTINUOUS CONVERTING ENZYME BLOCKADE ON RENOVASCULAR HYPERTENSION IN THE RAT [J].
FREEMAN, RH ;
DAVIS, JO ;
WATKINS, BE ;
STEPHENS, GA ;
DEFORREST, JM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1979, 236 (01) :F21-F24